title: Inositol 1,4,5-triphosphate drives glutamatergic and cholinergic inhibition selectively in spiny projection neurons in the striatum.
abstract: The striatum is critically involved in the selection of appropriate actions in a constantly changing environment. The spiking activity of striatal spiny projection neurons (SPNs), driven by extrinsic glutamatergic inputs, is shaped by local GABAergic and cholinergic networks. For example, it is well established that different types of GABAergic interneurons, activated by extrinsic glutamatergic and local cholinergic inputs, mediate powerful feedforward inhibition of SPN activity. In this study, using mouse striatal slices, we show that glutamatergic and cholinergic inputs exert direct inhibitory regulation of SPN activity via activation of metabotropic glutamate receptors (mGluRs) and muscarinic acetylcholine receptors. While pressure ejection of the group I mGluR (mGluR1/5) agonist DHPG [(S)-3,5-dihydroxyphenylglycine] equally engages both mGluR1 and mGluR5 subtypes, the mGluR-dependent component of IPSCs elicited by intrastriatal electrical stimulation is almost exclusively mediated by the mGluR1 subtype. Ca(2+) release from intracellular stores specifically through inositol 1,4,5-triphospahte receptors (IP(3)Rs) and not ryanodine receptors (RyRs) mediates this form of inhibition by gating two types of Ca(2+)-activated K(+) channels (i.e., small-conductance SK channels and large-conductance BK channels). Conversely, spike-evoked Ca(2+) influx triggers Ca(2+) release solely through RyRs to generate SK-dependent slow afterhyperpolarizations, demonstrating functional segregation of IP(3)Rs and RyRs. Finally, IP(3)-induced Ca(2+) release is uniquely observed in SPNs and not in different types of interneurons in the striatum. These results demonstrate that IP(3)-mediated activation of SK and BK channels provides a robust mechanism for glutamatergic and cholinergic inputs to selectively suppress striatal output neuron activity.
authors: Waggoner Center for Alcohol and Addiction Research, Section of Neurobiology, University of Texas, Austin, Austin, Texas 78712, USA.
authors: Michael A
authors: MA
authors: Clements
authors: Immani
authors: I
authors: Swapna
authors: Hitoshi
authors: H
authors: Morikawa
mesh_terms: D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology*; D053496:Inositol 1,4,5-Trisphosphate Receptors / Q000502:physiology*; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D009433:Neural Inhibition / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D018094:Receptors, Metabotropic Glutamate / Q000819:agonists / Q000502:physiology*; D011976:Receptors, Muscarinic / Q000502:physiology*
chemical_list: D053496:Inositol 1,4,5-Trisphosphate Receptors; D018094:Receptors, Metabotropic Glutamate; D011976:Receptors, Muscarinic; D008734:Methoxyhydroxyphenylglycol; C010117:3,4-dihydroxyphenylglycol
references: EMBO J. 2007 Apr 4;26(7):1924-33
references: 17347645
references: J Neurosci. 2006 Oct 25;26(43):11001-13
references: 17065442
references: J Neurophysiol. 1989 Apr;61(4):814-32
references: 2723722
references: J Physiol. 1995 Sep 1;487 ( Pt 2):343-58
references: 8558468
references: Science. 1994 Sep 23;265(5180):1826-31
references: 8091209
references: J Biol Chem. 1989 Oct 25;264(30):17816-23
references: 2530215
references: Proc Natl Acad Sci U S A. 1980 Dec;77(12):7237-41
references: 6938971
references: J Neurosci. 2008 Mar 19;28(12):3209-20
references: 18354024
references: J Neurosci. 2007 Apr 25;27(17):4776-85
references: 17460090
references: J Neurosci. 2005 Nov 2;25(44):10308-20
references: 16267239
references: Neuron. 1991 Aug;7(2):257-64
references: 1873029
references: J Neurosci. 2003 Apr 1;23(7):2600-7
references: 12684445
references: Pflugers Arch. 2005 Oct;451(1):105-15
references: 15924238
references: J Neurosci. 2008 Nov 5;28(45):11603-14
references: 18987196
references: Brain Res Rev. 2008 Aug;58(2):272-81
references: 18054796
references: J Neurosci. 2010 Apr 28;30(17):5894-911
references: 20427650
references: J Neurosci. 2003 Feb 1;23(3):758-65
references: 12574404
references: Nature. 1998 Jul 30;394(6692):475-8
references: 9697769
references: J Neurosci. 1993 Jul;13(7):3051-63
references: 8392539
references: Proc Natl Acad Sci U S A. 2012 May 15;109(20):7917-22
references: 22547800
references: J Neurosci. 2005 Nov 2;25(44):10230-8
references: 16267230
references: Trends Neurosci. 2007 May;30(5):228-35
references: 17408758
references: Neuroscience. 2001;103(4):1017-24
references: 11301208
references: Nat Neurosci. 2011 Dec 11;15(1):123-30
references: 22158514
references: Neuron. 2001 Aug 30;31(4):607-16
references: 11545719
references: Trends Pharmacol Sci. 1994 May;15(5):145-9
references: 7754532
references: J Neurosci. 2010 Mar 31;30(13):4746-56
references: 20357125
references: J Neurosci. 2003 Jan 1;23(1):149-57
references: 12514211
references: Science. 2010 Dec 17;330(6011):1677-81
references: 21164015
references: Nature. 2010 Jul 22;466(7305):513-6
references: 20613726
references: Biochemistry. 1989 Apr 18;28(8):3272-80
references: 2787165
references: J Comp Neurol. 2007 Feb 1;500(4):788-806
references: 17154259
references: Nat Rev Neurosci. 2011 Dec 20;13(1):7-21
references: 22183436
references: J Physiol. 2005 Jan 15;562(Pt 2):439-53
references: 15550460
references: J Neurosci. 2000 Nov 15;20(22):8365-76
references: 11069943
references: J Physiol. 2007 Oct 1;584(Pt 1):75-87
references: 17690146
references: J Neurosci. 2000 Oct 15;20(20):RC103
references: 11027254
references: J Neurosci. 2003 Aug 20;23(20):7659-69
references: 12930805
references: J Neurosci. 1993 Nov;13(11):4908-23
references: 7693897
references: Neuron. 2008 Sep 25;59(6):873-81
references: 18817728
references: J Physiol. 2011 Jul 1;589(Pt 13):3211-29
references: 21576272
references: Prog Neurobiol. 2004 Dec;74(5):271-300
references: 15582223
references: Cereb Cortex. 2008 Feb;18(2):407-23
references: 17573372
references: Trends Neurosci. 2012 Sep;35(9):557-64
references: 22858522
references: J Physiol. 2006 May 15;573(Pt 1):65-82
references: 16497716
references: Neuropharmacology. 1999 Oct;38(10):1431-76
references: 10530808
references: Chem Biol. 2011 Jun 24;18(6):777-93
references: 21700213
references: J Biol Chem. 1988 Aug 15;263(23):11075-9
references: 3136153
references: J Neurosci. 2002 May 1;22(9):3454-62
references: 11978822
references: Neuroscience. 1996 Apr;71(4):937-47
references: 8684624
references: Brain Res. 1997 May 9;756(1-2):9-21
references: 9187309
references: J Neurophysiol. 1992 Jul;68(1):287-94
references: 1381420
references: Nature. 2010 Jul 22;466(7305):457-62
references: 20651684
references: Pharmacol Rev. 1997 Mar;49(1):1-51
references: 9085308
references: Trends Pharmacol Sci. 2004 Dec;25(12):633-9
references: 15530641
references: J Neurosci. 2000 Oct 15;20(20):7855-60
references: 11027251
references: J Neurosci. 1996 Apr 1;16(7):2397-410
references: 8601819
references: J Neurophysiol. 1994 Jan;71(1):17-32
references: 8158226
references: J Neurosci. 1995 Jun;15(6):4449-63
references: 7790919
references: Neuron. 1998 Jul;21(1):13-26
references: 9697848
references: J Neurosci. 2005 Aug 10;25(32):7449-58
references: 16093396
references: Eur J Neurosci. 2010 Jun;31(11):1946-59
references: 20497469